Preclinical assessment of the abuse potential of purified botanical cannabidiol: self-administration, drug discrimination, and physical dependence

¹GW Pharmaceuticals, United Kingdom
²DevelRx, United Kingdom
³Pharmacology, UTHSCSA, United States
⁴Pharmacology, University of Texas Health Science Center, United States
⁵Psychiatry, University of Texas HSC, United States
⁶Department of Pharmacology, University of Texas Health Science Center, United States

↵* Corresponding Author:
Charles P. France, Department of Pharmacology, University of Texas Health Science Center, 7703 Floyd Curl Drive, Mail Code 7764, San Antonio, Texas, 78229-3900, United States. E-mail: france{at}uthscsa.edu
* Corresponding Author; email: roy_a_gray{at}outlook.com